Neil is a consultant urological surgeon specialising in the treatment of Benign Prostate Enlargement using the latest minimally invasive techniques including Aquablation of the prostate using the Aquabeam system, Greenlight laser, Urolift, Rezum and iTIND. He is also a renal cancer specialist, using robotic techniques for removal of kidney tumours and obstructions with both the Da Vinci and Versius robot systems.
Selected publications from PubMed
Predictors of durability of the prostatic urethral lift (PUL) for benign prostatic hyperplasia.
Eure G, Ashley M, Rukstalis DB, Chin P, Barber N, Roehrborn C
Prostate Cancer Prostatic Dis. 2026 Oct;29(4):836-839 doi: 10.1038/s41391-026-01101-y.
WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms.
Ritter M, Stein J, Barber N, Kalsi J, Popert R, Bass E, Németh R, Schmid M, Gloger S, Ubrig B, Miernik A, Gratzke C
Eur Urol Focus. 2026 Mar;12(2):266-274 doi: 10.1016/j.euf.2026.01.006.
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.
Dabestani S, Azawi NH, Campi R, Järvinen P, Nisen H, Capitanio U, Nielsen TK, Simone G, Rochester M, Green E, Fernandez-Pello S, Blick C, Porpiglia F, Ingels A, Bratulic S, Antonelli A, Hakimi AA, Jewett MAS, Ljungberg B, Bhindi B, Marconi L, Laird A, Stewart GD, Nair R, Lund L, Barber N, Master VA, Minervini A, Karam JA, Gatto F, Bex A
Eur Urol Oncol. 2025 Dec;8(6):1566-1574 doi: 10.1016/j.euo.2025.07.011.
Outcomes of aquablation: pooled analysis from the WATER, WATER II, OPEN WATER, FRANCAIS WATER, and JAPAN PMS studies.
Siqueira MHB, Berjaoui MB, Bhojani N, Te A, Gilling P, Badlani G, Barber N, Bach T, Misrai V, Hinata N, Koike S, Elterman D
World J Urol. 2025 Oct 28;43(1):635 doi: 10.1007/s00345-025-06033-1.
Pneumomediastinum as a complication of robotic-assisted radical nephrectomy: A case report.
Nafie A, Agag A, Reekhaye A, Hussain M, Malki M, Barber N
Bladder (San Franc). 2025;12(4):e21200069 doi: 10.14440/bladder.0194.
The last decade has seen a significant shift and growth in the surgical options available in the management of symptomatic BPH. Not least driven by patients keen to take up options that avoid a general anaesthetic, that are truly ambulatory, allowing a more rapid return to normal activities but also that avoid the risk of significant post-operative complications, including the development of permanent dry ejaculation and/ or impotence.
With Olympus
Published
Mar 2023
Welcome & Introduction. Dr. Christian Gratzke (Germany) Prioritizing Urological Surgery in the Covid-19 Era: Novel Recommendations and Guidelines. Dr. Christian Gratzke (Germany) Which challenges does COVID-19 trigger in BPH treatment in my country? Spanish perspective. Dr. Eduardo García Cruz (Spain) Post-COVID BPH Care: Could this open up new opportunities for minimally invasive BPH procedures? Dr. Neil Barber (UK) Post-COVID BPH Care: Could shifting procedures to day care solve current COVID-19 challenges by reducing waiting lists? Dr. Helena Burden (UK). Panel Discussion.All Faculty. Moderated by Dr. Christian Gratzke (Germany). Panel discussionAll Faculty. Moderated by Dr. Christian Gratzke (Germany).
With Olympus
Published
May 2021
Help your network discover Dr. Neil Barber's clinical expertise.
